HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A comparative study of treatment outcomes between begg and edgewise orthodontic systems in class I cases.

AbstractBACKGROUND:
The purpose of this study was to compare the occlusal peer assessment rating (PAR) index in Class I patients treated by means of Begg and Edgewise methods.
MATERIALS AND METHODS:
The pre- and post-treatment study models of Class I patients, referred to two private clinics, treated with Begg method (n = 30) and standard Edgewise method (n = 30), were reviewed retrospectively using PAR index including dental displacements, buccal occlusion (anteroposterior, vertical and transverse), overjet, overbite and midline parameters. The changes in PAR indices were analyzed using paired t-test. A P < 0.05 was considered as statistically significant.
RESULTS:
There was no significant difference in sex and age distribution between the two groups. The improvement of buccal occlusion in patients treated by Begg method (1.51 ± 0.39) was significantly higher than that of patients treated by Edgewise method (0.28 ± 0.39). The duration of treatment in Begg method (17.8 ± 1.3 months) was significantly shorter than that of Edgewise method (23.7 ± 1.3 months). However, there were no significant differences between the two methods in terms of total PAR index, dental displacements, overjet, overbite and midline.
CONCLUSION:
In conclusion, findings of the present study indicated that Begg method might be associated with better improvement of buccal occlusion and shorter duration of treatment.
AuthorsAbas Ali Sahafian, Farzin Heravi, Morteza Oshagh, Leila Adab
JournalDental research journal (Dent Res J (Isfahan)) Vol. 11 Issue 5 Pg. 574-8 (Sep 2014) ISSN: 1735-3327 [Print] Iran
PMID25426149 (Publication Type: Journal Article)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: